Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

Shingles can be an extremely painful condition and complications can be long-lasting, particularly for older people and those ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Two words come to mind for Elizabeth Banks after her showdown with shingles: "Not fun." ...

At present, Shingrix is used to prevent herpes zoster (shingles), a painful skin rash caused by the varicella-zoster virus.

Sen. Tammy Baldwin (D-Wis.) and Sen. Peter Welch (D-Vt.) will host a forum on Wednesday, March 26, to discuss how delayed NIH ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...